BUCKINGHAM STRATEGIC WEALTH, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 80 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
BUCKINGHAM STRATEGIC WEALTH, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$844,595
+22.4%
31,0000.0%0.01%
+20.0%
Q2 2023$689,750
+9.2%
31,000
-0.3%
0.01%
-9.1%
Q1 2023$631,7430.0%31,1050.0%0.01%0.0%
Q4 2022$631,743
-8.7%
31,105
+15.2%
0.01%
-21.4%
Q3 2022$692,000
+7.8%
27,0000.0%0.01%
+7.7%
Q2 2022$642,000
+5.6%
27,0000.0%0.01%
+8.3%
Q1 2022$608,000
+13.6%
27,0000.0%0.01%
+20.0%
Q4 2021$535,000
+0.8%
27,0000.0%0.01%
-9.1%
Q3 2021$531,000
-10.6%
27,0000.0%0.01%
-21.4%
Q2 2021$594,000
-7.5%
27,0000.0%0.01%
-56.2%
Q1 2021$642,000
-9.1%
27,0000.0%0.03%
-13.5%
Q4 2020$706,000
+50.2%
27,0000.0%0.04%
+2.8%
Q3 2020$470,000
+79.4%
27,000
+22.7%
0.04%
+44.0%
Q1 2020$262,000
-1.5%
22,0000.0%0.02%
-3.8%
Q4 2019$266,000
-14.5%
22,0000.0%0.03%
-23.5%
Q3 2019$311,000
+26.9%
22,0000.0%0.03%
+25.9%
Q2 2019$245,000
-5.0%
22,0000.0%0.03%
-18.2%
Q1 2019$258,000
-12.2%
22,0000.0%0.03%
-26.7%
Q4 2018$294,000
+5.0%
22,000
+10.0%
0.04%
+4.7%
Q3 2018$280,000
-10.8%
20,0000.0%0.04%
-15.7%
Q2 2018$314,000
-13.0%
20,0000.0%0.05%
-32.0%
Q4 2017$361,000
-6.5%
20,0000.0%0.08%
-18.5%
Q3 2017$386,000
+63.6%
20,0000.0%0.09%
+67.3%
Q2 2017$236,000
+7.8%
20,0000.0%0.06%
-14.1%
Q1 2017$219,000
+51.0%
20,0000.0%0.06%
+36.2%
Q4 2016$145,000
+11.5%
20,0000.0%0.05%
+6.8%
Q3 2016$130,000
+19.3%
20,0000.0%0.04%
+18.9%
Q2 2016$109,000
+16.0%
20,0000.0%0.04%
+19.4%
Q1 2016$94,000
-6.0%
20,0000.0%0.03%
-8.8%
Q4 2015$100,000
+33.3%
20,0000.0%0.03%
+30.8%
Q3 2015$75,000
-37.5%
20,0000.0%0.03%
-33.3%
Q2 2015$120,000
+7.1%
20,0000.0%0.04%
-7.1%
Q1 2015$112,000
+86.7%
20,0000.0%0.04%
+82.6%
Q4 2014$60,000
+11.1%
20,0000.0%0.02%
+4.5%
Q3 2014$54,000
-3.6%
20,0000.0%0.02%
-8.3%
Q2 2014$56,000
-35.6%
20,0000.0%0.02%
-40.0%
Q1 2014$87,000
+35.9%
20,0000.0%0.04%
+33.3%
Q4 2013$64,000
+100.0%
20,0000.0%0.03%
+76.5%
Q3 2013$32,000
-8.6%
20,0000.0%0.02%
-15.0%
Q2 2013$35,00020,0000.02%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders